newsfilter
← Latest News
ACCESS Newswire·

Lexaria Files Pre-IND Meeting Request Letter with U.S. FDA

KELOWNA, BC / ACCESSWIRE / June 6, 2022 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce it has successfully filed a pre-Investigational New Drug ("I